Transgene Biotek informs about standalone financial results

01 Jul 2014 Evaluate

Transgene Biotek has informed about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2014.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

7.07 0.14 (2.02%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.